Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2022-03-31 Audit Report / Informat…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Sprawozdanie z badania SF_ENG
Audit Report / Information Classification · 99% confidence The document explicitly contains the heading "INDEPENDENT AUDITOR'S REPORT ON THE AUDIT" and further specifies "Audit report on the annual financial statements". It details the auditor's opinion on the financial statements for the period ending 31 December 2021, referencing compliance with the Accounting Act and discussing key audit matters. This content is characteristic of a formal Audit Report, which aligns with the definition for Code AR (Audit Report / Information), distinguishing it from the full Annual Report (10-K) or a mere announcement of a report (RPA). FY 2021
2022-03-31 English
Sprawozdanie z badania SF_PL
Audit Report / Information Classification · 99% confidence The document text is explicitly titled "SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA" (Independent Auditor's Report on the Audit) and discusses the audit of the annual financial statements for the period ending December 31, 2021. This content directly corresponds to the definition of an Audit Report/Information, which covers standalone audit reports and applied accounting principles. Although it relates to the annual period, the core document type is the audit opinion itself, not the full Annual Report (10-K). Therefore, the appropriate code is AR. FY 2021
2022-03-31 Polish
Sprawozdanie finansowe jednostkowe_Selvita SA_za 2021
Audit Report / Information Classification · 98% confidence The document is titled "SPRAWOZDANIE FINANSOWE ZA OKRES OD 01.01.2021 R. DO 31.12.2021 R." which translates to "FINANCIAL STATEMENT FOR THE PERIOD FROM 01.01.2021 TO 31.12.2021". It contains a detailed table of contents listing core financial statements: Balance Sheet (Bilans), Income Statement (Rachunek zysków i strat), Statement of Changes in Equity (Zestawienie zmian w kapitale własnym), Cash Flow Statement (Rachunek przepływów pieniężnych), and Notes (Dodatkowe informacje i objaśnienia). Furthermore, it details accounting policies (Przyjęte zasady (polityka) rachunkowości) for fixed assets, intangible assets, and financial instruments. This comprehensive structure covering a full fiscal year (01.01.2021 to 31.12.2021) strongly indicates a full annual financial report, which corresponds to the 10-K filing type, even though the document is in Polish and not explicitly labeled as a US SEC Form 10-K. Given the context of comprehensive annual financial reporting, 10-K is the most appropriate classification among the provided options, as 'AR' (Audit Report) is usually a standalone component or stress test result, whereas this is the full set of statements. FY 2021
2022-03-31 Polish
Sprawozdanie Zarządu Selvita SA z działalności za rok 2021
Audit Report / Information Classification · 98% confidence The document is titled "SPRAWOZDANIE ZARZĄDU z działalności Selvita S.A. za rok obrotowy 2021" (Management Board Report on the activities of Selvita S.A. for the financial year 2021) and covers the period 01.01.2021 - 31.12.2021. It contains a detailed Table of Contents covering financial results, operational activities, risk factors, governance, and accounting principles. The content includes comprehensive financial tables (income statement data, cash flows) comparing 2021 results to 2020. This structure and content strongly indicate a full annual report, which corresponds to the definition of a 10-K (Annual Report), even though the document is in Polish and likely filed with a local regulator, the classification maps best to the comprehensive annual filing type. FY 2021
2022-03-31 Polish
List Prezesa Zarządu do Akcjonariuszy_raport roczny 2021_ENG
Earnings Release Classification · 95% confidence The document is a letter addressed to 'Dear Shareholders, Business Partners, and Friends' from the CEO, Boguslaw Sieczkowski. It reviews the past year's performance, highlights achievements (acquisitions, organic growth, segment performance like Fidelta, Ardigen), discusses strategic progress against a 2020-2023 plan, mentions future plans (new strategy, Krakow research center), and thanks shareholders and the team. This content structure—a comprehensive review and outlook from management to stakeholders—is characteristic of an Annual Report (10-K) or a section within it, or potentially an Annual Report Letter (AR). Since the text provides a detailed narrative summary of the entire year's operations, strategy, and financial context, it strongly aligns with the content expected in an Annual Report (10-K) or a Management Discussion & Analysis (MDA) section thereof. Given the high-level, narrative, and forward-looking nature typical of a CEO's letter accompanying the full annual results, and lacking specific regulatory headers or explicit mention of being a 'release' or 'transcript', it is most likely part of the Annual Report package. However, since the provided definitions separate 10-K (Official yearly report) from MDA (Management's detailed explanation), and this reads like the introductory letter often found in the 10-K or a standalone Annual Report document, 10-K is the most appropriate classification for a comprehensive yearly review document. FY 2021
2022-03-31 English
List Prezesa Zarządu do Akcjonariuszy_raport roczny 2021_PL
Management Reports Classification · 95% confidence The document is a letter from the CEO (Bogusław Sieczkowski) addressed to shareholders, summarizing the company's performance, strategic achievements, and future outlook for the fiscal year 2021. It discusses business segments, acquisitions (Fidelta), and growth milestones. This type of narrative summary, typically found at the beginning of an annual report or as a standalone management review, fits the definition of a Management Report (MDA) as it provides a detailed explanation of business trends and outlook. FY 2021
2022-03-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.